There are 398 resources available
Patient attrition across lines of treatment for metastatic disease in the real world
Presenter: Filippo Montemurro
Session: Lessons from real world data
Resources:
Slides
Webcast
1MO - Prognostic and biologic significance of HER2-low expression in early breast cancer
Presenter: Paolo Tarantino
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
Endocrine therapy beyond 5 years: Who to treat and for what duration
Presenter: Lucia Del Mastro
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
Therapy landscapes and molecular markers, the German PRAEGNANT registry
Presenter: Andreas Hartkopf
Session: Lessons from real world data
Resources:
Slides
Webcast
2MO - Development of a prognostic gene-expression signature for early stage HER2-positive breast cancer patients
Presenter: Serena Di Cosimo
Session: Mini Oral session 3
Resources:
Abstract
Slides
Optimal management of endocrine therapy toxicity
Presenter: Hope Rugo
Session: Adjuvant treatment luminal in breast cancer
Resources:
Slides
Webcast
Enabling large scale analysis: The ESME Project
Presenter: Thomas Grinda
Session: Lessons from real world data
Resources:
Slides
Webcast
3MO - Association of the research-based HER2DX signatures with survival in early-stage triple-negative breast cancer (eTNBC)
Presenter: Benedetta Conte
Session: Mini Oral session 3
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Adjuvant treatment luminal in breast cancer
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Lessons from real world data
Resources:
Webcast